Lv2
170 积分 2024-07-09 加入
Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
1个月前
已完结
Investigating combined hypoxia and stemness indices for prognostic transcripts in gastric cancer: Machine learning and network analysis approaches
1个月前
已完结
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD
2个月前
已关闭
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
3个月前
已完结
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study)
3个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
4个月前
已完结
基于Ki67构建晚期胃癌预后的预测模型
5个月前
已关闭
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
5个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
5个月前
已完结
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial
5个月前
已完结
皖公网安备34019202002308
